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Pressurized intraperitoneal aerosol chemotherapy (PIPAC),
a new surgical technique for the treatment of unresectable
peritoneal carcinomatosis.
Background
Patients with unresectable peritoneal carcinomatosis treated with systemic chemotherapeutics have
a bad prognosis. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) can be a valuable
adjunct. PIPAC is a minimally invasive and repeatable technique to deliver chemotherapeutic drugs
into the peritoneal cavity. We report about the practical organization and implementation of this
technique, its indications and its impact on patients’ early postoperative recovery.
Cosyns Sarah (PhD, MSc), Van de Sande Leen (Msc), Ceelen Wim (FACS, MD, PhD), Willaert Wouter (MD, PhD),
Department of Surgery, Ghent University Hospital, Ghent, Belgium. Corresponding author: sarah.cosyns@ugent.be.
Methods
Every practical step until the first procedure was retrospectively reviewed together with the
indications to perform this technique, the number of procedures in each patient and the early
postoperative recovery.
PIPAC technique (Solass et al., 2014)
Results
Conclusion
PIPAC is a new surgical procedure for the treatment of unresectable peritoneal carcinomatosis. This technique is safe for the surgical team
under controlled circumstances. Its practical implementation requires extensive teamwork. The impact of this chemotherapeutic procedure on
patients’ postoperative recovery is limited. In the near future, we will start with an experimental study on PIPAC.
Tumor Number
Colon adenocarcinoma 7
Gastric adenocarcinoma 6
Serous ovarian carcinoma 3
Esophageal adenocarcinoma 2
Gall bladder carcinoma 1
Ductal breast carcinoma 1
Mesothelioma 1
Small bowel adenocarcinoma 1
MANEC 1
LAMN 1
CUP 1
PIPACs at Ghent University Hospital*
* Data collected over a period of 13 months: 49 procedures in 25 patients
(9 patients underwent 3 procedures, 6 patients underwent 2 procedures, 10
patients underwent 1 procedure). Surgeries occurred uneventful.
Concomitant chemotherapy: n = 11; Laparotomy: n = 4
Postoperative recovery
Mainly uneventful:
• Local pain
• Subileus
• Nausea
• CRP increase (2-3 days 
postop: 100-150 mg/l)
• Fever
One patient developed toxic 
inflammation of the abdominal 
wall (which was successfully 
treated with antibiotics)
Safety measures: standard operating 
procedures strictly implemented!
Protection
Closed system
Remote control
Safety checklist 
Air contamination? 
Air sampling in the operating room 
during 2 PIPAC procedures
Platinum concentrations were not 
increased
• Not eligible for cytoreductive
surgery + HIPEC
• Palliative systemic
chemotherapy relapse or non-
responders
Indications for PIPAC
Effect of Electrostatic Precipitation (E)PIPAC on peritoneal carcinomatosis in a patient with MANEC
Diffuse peritoneal carcinomatosis (white star) in the right hypochondrium before EPIPAC (A). Gradual blurring of
peritoneal carcinomatosis and development of adhesions between the right liver lobe and peritoneum of the right
diaphragmatic dome (white star) during consecutive EPIPACs (B,C). Peritoneal carcinomatosis at the left
diaphragmatic dome (black star) remains stable after 2 EPIPACs, but ascites appears in the left hypochondrium (white
arrow) (D,E,F).
